Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Zingo | Lidocaine Hydrochloride Monohydrate Powder while breastfeeding. We will also discuss about common side effects and warnings associated with Zingo | Lidocaine Hydrochloride Monohydrate Powder.
What is Zingo | Lidocaine Hydrochloride Monohydrate Powder used for?
Zingo™ is indicated for use on intact skin to provide topical local analgesia prior to venipuncture or peripheral intravenous cannulation, in children 3–18 years of age. Zingo™ is indicated for use on intact skin to provide topical local analgesia prior to venipuncture in adults. Zingo™ is an amide local anesthetic indicated for use on intact skin to provide local analgesia prior to venipuncture or peripheral intravenous cannulation in children 3–18 years of age. (1) Zingo™ is indicated for use on intact skin to provide topical local analgesia prior to venipuncture in adults. (1) Important Limitations: For use on intact skin only (1, 2) For external use only (5)
Is using Zingo | Lidocaine Hydrochloride Monohydrate Powder unsafe in breastfeeding? Can there be bad consequences for baby if I use it while breastfeeding?
Active ingredient in Zingo | Lidocaine Hydrochloride Monohydrate Powder is Lidocaine hydrochloride anhydrous and based on our analysis of Lidocaine hydrochloride anhydrous it appears that using Zingo | Lidocaine Hydrochloride Monohydrate Powder is safe in breastfeeding. Below is analysis of Lidocaine hydrochloride anhydrous while breastfeeding.
Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Lidocaine is excreted into human milk; therefore, caution should be exercised when Zingo™ is administered to a nursing mother. Because no plasma concentrations of lidocaine are detected after topical administration of Zingo™ in recommended doses, the small amount of lidocaine that would be ingested orally by a suckling infant is unlikely to cause adverse effects.
Zingo | Lidocaine Hydrochloride Monohydrate Powder Breastfeeding Analsys
SafeCAS Number: 137-58-6
Compatible with breastfeeding no matter the multiple ways it can be used: anesthetic, anti-arrhythmic, or anti-epileptic drug. Excreted into breast milk in non-significant amount with no side effects on breastfed infants from treated mothers. As a topical anesthetic (dermatologic, dental-stomatologic, ophtalmotologic and otologic preparations) it has an almost nil systemic absorption. Avoid using it on the nipple, but if necessary do it after the breast feed, wipe it out and rinse with water before the next feed, An euptectic mixture with added Prilocaine (EMLA) is used for dermatologic anesthesia. There is an increased risk of Methemoglobinemia when applied on large surfaces or taken by mouth. Intrapartum anesthesia may delay the onset of phase II of Lactogenesis or milk coming-in. The American Academy of Pediatrics rates it usually compatible with Breastfeeding.
Zingo | Lidocaine Hydrochloride Monohydrate Powder Breastfeeding Analsys - 2
CAS Number: 137-58-6
Lidocaine concentrations in milk during continuous IV infusion, epidural administration and in high doses as a local anesthetic are low and the lidocaine is poorly absorbed by the infant. Lidocaine is not expected to cause any adverse effects in breastfed infants. No special precautions are required.[1][2][3] Lidocaine labor and delivery with other anesthetics and analgesics has been reported by some to interfere with breastfeeding. However, this assessment is controversial and complex because of the many different combinations of drugs, dosages and patient populations studied as well as the variety of techniques used and deficient design of many of the studies. Overall it appears that with good breastfeeding support epidural lidocaine with or without fentanyl or one of its derivatives has little or no adverse effect on breastfeeding success.[4][5][6][7][8] Labor pain medication may delay the onset of lactation.
What should I do if already breastfed my kid after using Zingo | Lidocaine Hydrochloride Monohydrate Powder?
As usage of Zingo | Lidocaine Hydrochloride Monohydrate Powder is mostly safe while breastfeeding hence there should not be any concern. In case of any change in behavior or health of your baby you should inform your health care provider about usage of Zingo | Lidocaine Hydrochloride Monohydrate Powder else no further action is required.
My health care provider has asked me to use Zingo | Lidocaine Hydrochloride Monohydrate Powder, what to do?
Usage of Zingo | Lidocaine Hydrochloride Monohydrate Powder is safe for nursing mothers and baby, No worries.
If I am using Zingo | Lidocaine Hydrochloride Monohydrate Powder, will my baby need extra monitoring?
No
Who can I talk to if I have questions about usage of Zingo | Lidocaine Hydrochloride Monohydrate Powder in breastfeeding?
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week